slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
127 TWD | +9,96% |
|
+35,54% | +118,59% |
Vakgebied
Verkoop per activiteit
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Stem Cell-related Products and Gene Testing
90,3
%
| 884 | 90,1 % | 1 018 | 90,3 % | +15,19% |
Other
9,7
%
| 97 | 9,9 % | 109 | 9,7 % | +13,10% |
Verkoop per regio
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Taiwan
98,5
%
| 960 | 98,0 % | 1 110 | 98,5 % | +15,57% |
Others
1,5
%
| 20 | 2,0 % | 17 | 1,5 % | -12,96% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Tien Lai Liu
CEO | Chief Executive Officer | - | 01-09-06 |
Pei Yi Liu
DFI | Director of Finance/CFO | - | 23-03-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shao Hua Huang
BRD | Director/Board Member | 75 | 21-11-06 |
Cheng Hsien Tsai
CHM | Chairman | - | 01-08-00 |
Wen Cheng Chang
BRD | Director/Board Member | - | 11-04-03 |
Wen Hsi Yan
BRD | Director/Board Member | - | 28-06-06 |
Pao Hsi Sheng
BRD | Director/Board Member | - | 27-06-19 |
Shih Ming Liang
BRD | Director/Board Member | - | 26-10-07 |
Han Tung Chang
BRD | Director/Board Member | - | 28-06-06 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 49 627 000 | 35 224 924 ( 70,98 %) | 2 330 000 ( 4,695 %) | 70,98 % |
Bedrijfsgegevens
![Adres BIONET Corp.(1784)](https://cdn.zonebourse.com/static/address/6499188.png)
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+118,59% | 185 mln. | |
+19,41% | 45,51 mld. | |
-8,62% | 38,52 mld. | |
+38,65% | 38,13 mld. | |
+26,95% | 30,74 mld. | |
-13,50% | 26,03 mld. | |
+10,74% | 25,92 mld. | |
+44,87% | 14,13 mld. | |
+34,36% | 12,73 mld. | |
-7,14% | 11,29 mld. |
- Beurs
- Aandelen
- Koers 1784
- Onderneming BIONET Corp.